While both the United States and Europe strive to provide optimal cancer care, their systems differ noticeably. The US often emphasizes cutting-edge treatments, sometimes leading to increased costs. In contrast, European systems tend to prioritize preventive care and accessibility, highlighting early diagnosis. This can result in different patient